Adding mitomycin to BCG as adjuvant intravesical therapy for high-risk, non–muscle-invasive bladder cancer: a 2-stage, randomised phase 3 trial

  • Hayne, Dickon (Investigator 01)
  • Stockler, Martin (Investigator 02)
  • Davis, Ian (Investigator 03)
  • Frydenberg, Mark (Investigator 04)
  • Martin, Andrew (Investigator 05)
  • Patel, Manish (Investigator 06)
  • Grummet, Jeremy (Investigator 07)
  • Krieger, Laurence (Investigator 08)
  • Lawrence, Nicola (Investigator 09)
  • Sengupta, Shomik (Investigator 10)

Project Details

StatusFinished
Effective start/end date1/01/18 → 1/01/23

Funding

  • NHMRC National Health and Medical Research Council